Such compounds would create a dominant-negative form of FANCM that retains DNA binding and core complex recruitment while blocking its ability to process DNA structures—precisely the combination that previous studies suggested would be most toxic to cancer cells (Lu et al, 2019; Panday et al, 2021; Silva et al, 2019). The gene discussed is FANCM; the disease is cancer.